MMRGlobal has received a significant intellectual property milestone payment pursuant to a non-exclusive license agreement pertaining to its biotech assets including vaccines and patient samples. Additional information will be included in a press release and the Company’s third quarter report ending September 30th, 2014. http://www.mmrontv.com/ or www.mmrglobal.com
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.